Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.

doi:10.1212/WNL.0000000000004803

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.

Neurology - 9 Jan 2018

Dubey Divyanshu, Lennon Vanda A, Gadoth Avi, Pittock Sean J, Flanagan Eoin P, Schmeling John E, McKeon Andrew, Klein Christopher J

Abstract excerpt

OBJECTIVE: To establish the phenotype and clinical outcomes of collapsin response-mediator protein-5 (CRMP5) autoimmune neuropathy in comparison with anti-neuronal nuclear antibody type 1 (ANNA1)-immunoglobulin G (IgG) neuropathy. METHODS: Patients with CRMP5-IgG and/or ANNA1-IgGs were identified in our service-line testing, and medical records were reviewed. RESULTS: One hundred five patients with CRMP5-IgG...

Topics

Adult
Aged
Aged, 80 and over
Antibodies, Antinuclear
Antibodies, Neoplasm
Autoantibodies
Autoimmune Diseases of the Nervous System
Cohort Studies
Female
Humans
Hydrolases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Immunoglobulin G

Immunotherapy

Male

Microtubule-Associated Proteins

Middle Aged

Neoplasms

Nerve Tissue Proteins

Source

Open in PubMed

Identifiers

PMID: 29222126
DOI: 10.1212/WNL.0000000000004803

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.PMID 29222126Read ↗

Phenotypic presentations of paraneoplastic neuropathies associated with MAP1B-IgGSemantic proximity Read ↗

Mechanism, and treatment of anti-CV2/CRMP5 autoimmune painSemantic proximity Read ↗

Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathiesSemantic proximity Read ↗

Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues.Semantic proximity Read ↗

Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy.Semantic proximity Read ↗

Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.Semantic proximity Read ↗

Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.Semantic proximity Read ↗

Clinical phenotype and prognostic determinants of spontaneous pneumomediastinum in anti-MDA5 antibody-positive dermatomyositis.Semantic proximity Read ↗

Analysis of 977 Long COVID Patients Reveals Prevalent Neuropathy and Association with Anti-Ganglioside AntibodiesSemantic proximity Read ↗

Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.Semantic proximity Read ↗

Anti-Plexin-D1 Seropositive Small Fiber Neuropathy: Clinical Phenotype, Demographics, and Literature Review.Semantic proximity Read ↗

CIDP With and Without Monoclonal Gammopathy of Undetermined Significance (MGUS): Comparison of Clinical Phenotype, Diagnostic Features, and Treatment Response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.